Period of time： 2014年3期
Publisher： Informa Healthcare
Founded in： 1997
Total resources： 110
ISSN： 1472-8222
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Therapeutic Targets,volume 7,issue 3
Menu
Vancomycin resistance: occurrence, mechanisms and strategies to combat it
By Boneca Ivo G,Chiosis Gabriela in (2003)
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.
Access to resources
Recommend
Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases
By Lecci Alessandro,Maggi Carlo Alberto in (2003)
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.The potential of antisense as a CNS therapeutic
By Godfray Jenny,Estibeiro Peter in (2003)
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.New therapeutic target in primary headaches – blocking the CGRP receptor
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.By Fingleton Barbara in (2003)
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.The coagulation system as a target for experimental therapy of human gliomas
By Loynes JT,Zacharski LR in (2003)
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.Antiangiogenic therapy through copper chelation
By Sproull Mary,Brechbiel Martin,Camphausen Kevin in (2003)
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.TNF-receptor-associated factors as targets for drug development
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.Secreted phospholipase A2 enzymes as therapeutic targets
By Scott Kieran F,Graham Garry G,Bryant Katherine J in (2003)
Expert Opinion on Therapeutic Targets,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-06 , pp.
Previous
Next